Auromilla Continu 0,02 mg - 3 mg film-coat. tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)

Disponibbli minn:

Aurobindo Pharma B.V.

Kodiċi ATC:

G03AA12

INN (Isem Internazzjonali):

Drospirenone; Ethinylestradiol; Placebo

Dożaġġ:

0,02 mg - 3 mg

Għamla farmaċewtika:

Film-coated tablet

Kompożizzjoni:

Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo

Rotta amministrattiva:

Oral use

Żona terapewtika:

Drospirenone and Ethinylestradiol

Sommarju tal-prodott:

CTI code: 449742-04 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 449742-03 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 449742-05 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 449742-02 - Pack size: 2 x 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 449742-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: No

Data ta 'l-awtorizzazzjoni:

2014-02-17